PURE BIOSCIENCE IN COM NPV (PURE)

0.96
0.02 1.94
OTC
Prev Close 0.98
Open 1.00
Day Low/High 0.96 / 1.00
52 Wk Low/High 0.75 / 1.36
Volume 3.24K
Exchange OTC
Shares Outstanding 62.94B
Market Cap 62.31M
Div & Yield N.A. (N.A)

Latest News

PURE Control® Antimicrobial Listed As Safe And Suitable Ingredient In The USDA-FSIS Directive 7120.1 For Poultry Products

PURE Control® Antimicrobial Listed As Safe And Suitable Ingredient In The USDA-FSIS Directive 7120.1 For Poultry Products

PURE Bioscience, Inc. ( OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate ( SDC) antimicrobial, today announced that PURE Control® antimicrobial is included in the newly updated list of Safe and...

PURE Bioscience To Present At 2017 Southern California Investor Conference

PURE Bioscience To Present At 2017 Southern California Investor Conference

PURE Bioscience, Inc. ( OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate ( SDC) antimicrobial, today announced that the Company will present at the 2017 Southern California Investor Conference on...

PURE Bioscience Appoints Food Supply Chain Executive Janet Risi To Its Board Of Directors

PURE Bioscience Appoints Food Supply Chain Executive Janet Risi To Its Board Of Directors

PURE Bioscience, Inc. ( OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate ( SDC) antimicrobial, today announced that it has named Janet Risi, President and CEO of Independent Purchasing Cooperative,...

PURE Bioscience Announces Co-Marketing And Supply Agreement With Roka Bioscience, Inc.

PURE Bioscience Announces Co-Marketing And Supply Agreement With Roka Bioscience, Inc.

PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today announced that it has entered into a two-year nonexclusive supply agreement with Roka...

PURE Bioscience Reports 2017 Fiscal Third Quarter And Nine-Month Financial Results

PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented non-toxic silver dihydrogen citrate ( SDC) antimicrobial, today reported financial results for the fiscal third quarter and nine-month periods ended...

PURE Bioscience To Present At The 2017 Marcum Microcap Conference

PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented non-toxic silver dihydrogen citrate ( SDC) antimicrobial, today announced that the Company will present at the 2017 Marcum Microcap Conference on June...

PURE Bioscience Sets Q3 Results Conference Call To Review Progress Of SDC-Based Antimicrobial Food Safety Solutions Strategy

PURE Bioscience, Inc. ( OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate ( SDC) antimicrobial, announced today that the Company will publish fiscal Q3 financial results shortly after the market...

PURE Bioscience Receives Final FDA Acknowledgement Letter

PURE Bioscience, Inc. ( OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate ( SDC) antimicrobial, announced that the Company has received final acknowledgement from the US Food and Drug Administration...

PURE Bioscience To Present At The B. Riley & Co. 18th Annual Investor Conference

PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented non-toxic silver dihydrogen citrate ( SDC) antimicrobial, today announced that the Company will present at the B.

PURE Bioscience Receives USDA Permission Letter And FDA FCN Acknowledgement Letter

PURE Bioscience, Inc. ( OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate ( SDC) antimicrobial, announced that the Company has received two required key regulatory notifications on the Company's path...

PURE Bioscience Receives First Order For PURE Control® Antimicrobial From A Leading Produce Processor

PURE Bioscience, Inc. ( OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate ( SDC) antimicrobial, announced that the Company had received and shipped its first order for FDA approved PURE...

PURE Bioscience Reports Improved 2017 Fiscal Second Quarter And Six-Month Financial Results

PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented non-toxic silver dihydrogen citrate ( SDC) antimicrobial, today reported financial results for the fiscal second quarter and six-month periods ended...

PureCircle Completes $42m Stevia Plant Expansion

-Doubles Capacity to Extract High Quality, Sustainable Stevia

PURE Bioscience To Present At The 29th Annual ROTH Capital Partners Conference

PURE Bioscience, Inc. ( OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate ( SDC) antimicrobial, announced today the Company will present at the 29th Annual ROTH Capital Partners Conference on March...

PURE Bioscience Sets Q2 Results Conference Call To Review Sales And Progress Of Its SDC-Based Antimicrobial Food Safety Solutions Strategy

PURE Bioscience, Inc. ( OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate ( SDC) antimicrobial, announced today that the Company will publish fiscal Q2 results after the market closes and host an...

PURE Bioscience Receives FDA Interim Safety Determination Authorization To Test Higher Concentrations Of SDC-Based PURE Control® Antimicrobial As A Poultry Processing Aid

PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the non-toxic, patented silver dihydrogen citrate ( SDC) antimicrobial, today announced the Company had received a Preliminary Notification (PNC) authorization letter...

Recent Norovirus Outbreaks In National Media Headlines - Highly Effective PURE® Hard Surface Disinfectant Kills Norovirus In 60 Seconds

PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented silver dihydrogen citrate ( SDC) antimicrobial, has published a Norovirus Technical Bulletin highlighting the unique and powerful effectiveness of...

PURE Bioscience Well Positioned To Provide Solutions To 2017's Key Food Safety Challenges

PURE Bioscience Well Positioned To Provide Solutions To 2017's Key Food Safety Challenges

PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented silver dihydrogen citrate ( SDC) antimicrobial, discusses the Company's positioning to address the major food safety challenges faced by food manufacturers and...

PURE Bioscience Reports Q1 2017 Financial Results

PURE Bioscience Reports Q1 2017 Financial Results

PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented silver dihydrogen citrate ( SDC) antimicrobial, today reported financial results for the fiscal first quarter ended October 31, 2016.

PURE Bioscience Sets Fiscal 2017 Q1 Results Conference Call

PURE Bioscience Sets Fiscal 2017 Q1 Results Conference Call

PURE Bioscience, Inc. ( OTCQB: PURE), creator of the patented silver dihydrogen citrate ( SDC) antimicrobial, announced today that on December 14, 2016 the Company will file its Form 10-Q shortly after the close of the...

PURE Bioscience Reports Fiscal 2016 Year-End Financial Results

PURE Bioscience Reports Fiscal 2016 Year-End Financial Results

PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented silver dihydrogen citrate ( SDC) antimicrobial, today reported financial results for the fiscal year ended July 31, 2016.

PURE Bioscience To Host Fiscal 2016 Year-End Financial Results Conference Call

PURE Bioscience To Host Fiscal 2016 Year-End Financial Results Conference Call

PURE Bioscience, Inc. ( OTCQB: PURE), creator of the patented silver dihydrogen citrate ( SDC) antimicrobial, announced today that on October 27, 2016 the Company will file its Form 10-K shortly after the close of the...

PURE® Hard Surface Disinfectant Included In Chipotle's Enhanced Restaurant Procedures

PURE® Hard Surface Disinfectant Included In Chipotle's Enhanced Restaurant Procedures

PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented silver dihydrogen citrate ( SDC) antimicrobial, today announced that Chipotle Mexican Grill, Inc.